NCT02574325View on ClinicalTrials.gov

A Study to Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic Steatosis

PHASE2UnknownINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2016

Study Completion Date

December 31, 2016

Conditions
Nonalcoholic Steatohepatitis
Interventions
DRUG

Placebo

Control

DRUG

ARI-3037MO

Treatment

Trial Locations (1)

63104

Gastroenterology & Hepatology CRU, St Louis University, St Louis

Sponsors
All Listed Sponsors
lead

Arisaph Pharmaceuticals Inc

INDUSTRY